Skip to content

Abbott Plans to Launch Health Wearables Outside the U.S. Later This Year

  • Lingo product line can be used to track diet, exercise
  • Opportunity over time could be bigger than diabetes, CEO says
Robert Ford introduces Abbott’s Lingo biowearables portfolio of products in Las Vegas, Nevada on Jan. 6. 
Robert Ford introduces Abbott’s Lingo biowearables portfolio of products in Las Vegas, Nevada on Jan. 6. Photographer: Ethan Miller/Getty Images

Abbott Laboratories is eyeing a launch of wearable products later this year for the general public outside the U.S., Chief Executive Officer Robert Ford said.

Ford described the new product line, called Lingo, as a major opportunity for the company that over time could be larger than the market for diabetes products. Its FreeStyle Libre diabetes monitors brought in about $1 billion of the company’s $11.5 billion in fourth-quarter revenue.